Pfizer still unable to get on top of problems at Hospira injectables plant

12th December 2018 Uncategorised 0

Since Pfizer’s Kansas plant received an FDA warning letter last year, the company has insisted it is making good progress on turning things around at the essential but troubled injectables facility. But the findings from the most recent inspection show problems persist, and most of them the FDA had flagged before.

More: Pfizer still unable to get on top of problems at Hospira injectables plant
Source: fierce